Hydromer, Inc. (OTC: HYDI), a specialist in medical coatings and surface technologies, has announced a new commercial partnership with Avem Market Solutions to strengthen its presence and technical support capabilities for medical device developers throughout Europe and the United Kingdom. The collaboration aims to make Hydromer's hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms more accessible to European manufacturers, offering custom formulation, R&D support, scalable coating equipment, and local commercial guidance.
Avem, based in Galway, Ireland, is known for connecting Medtech OEMs and CDMOs with specialized suppliers for contract design and manufacturing services, as well as supporting early-stage development and market growth. As Hydromer's strategic representative in the region, Avem will provide a direct channel for device manufacturers to explore coating technologies proven in global markets. This partnership brings together Hydromer's scientific expertise with Avem's regional market insight to help developers reduce time to market, enhance device performance, and streamline the transition from prototype to full-scale manufacturing.
European and UK medtech companies face increasing pressure to innovate quickly while meeting strict regulatory expectations. According to Hydromer, the partnership is designed to eliminate barriers and empower innovators at every stage of product development. By combining Hydromer's technical capabilities with Avem's network and on-the-ground presence, device manufacturers gain earlier visibility into validated coating options, hands-on support for feasibility studies and scale-up, and a reliable resource for navigating technical and operational challenges.
For more information about Hydromer's coating technologies, visit the company's website at https://www.hydromer.com. Further details about Avem Market Solutions can be found at https://www.avemmarketsolutions.com.
